Usefulness of cytokeratin subsets for distinguishing monophasic synovial sarcoma from malignant peripheral nerve sheath tumor

American Journal of Clinical Pathology

Volumn 112, Issue 5, 1999, Pages 641-648

  Smith, Tamara A ^a   Machen, S Karen ^a   Fisher, Cyril ^b   Goldblum, John R ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Cytokeratin; Malignant peripheral nerve sheath tumor; Monophasic synovial sarcoma

Indexed keywords

ANTIBODY; CYTOKERATIN; CYTOKERATIN 19; CYTOKERATIN 7; EPITHELIAL MEMBRANE ANTIGEN; PROTEIN S 100;

ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; NERVE SHEATH TUMOR; NEURILEMOMA; NEUROFIBROMA; NEUROFIBROMATOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINDLE CELL SARCOMA; SYNOVIAL SARCOMA;

EID: 0033490215     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/112.5.641     Document Type: Article

References (34)

1. Guillou L, Wadden C, Kraus MD, et al. S-100 protein reactivity in synovial sarcomas: a potentially frequent diagnostic pitfall: immunohistochemical analysis of 100 cases. Appl Immunohistochem. 1996;4:167-175.
2. Daimaru Y, Hashimoto H, Enjoji M. Malignant peripheral nerve-sheath tumors (malignant schwannomas): an immunohistochemical study of 29 cases. Am J Surg Pathol. 1985;9:434-444.
3. Weiss SW, Langloss JM, Enzinger FM. Value of S-100 protein in the diagnosis of soft tissue tumors with particular reference to benign and malignant Schwann cell tumors. Lab Invest. 1983;49:229-308.
4. Abenoza P, Manival C, Swanson PE, et al. Synovial sarcoma: ultrastructural study and immunohistochemical analysis by a combined peroxidase-antiperoxidase/avidin-biotin-peroxidase complex procedure. Hum Pathol. 1986;17:1107-1015.
5. Ordonez NG, Mahfouz SM, Mackay B. Synovial sarcoma: an immunohistochemical and ultrastructural study. Hum Pathol. 1990;21:733-749.
6. Fisher C. Synovial sarcoma: ultrastructural and immunohistochemical features of monophasic and biphasic tumours. Hum Pathol. 1986;17:996-1008.
7. Salisbury JR, Isaacson PG. Synovial sarcoma: an immunohistochemical study. J Pathol. 1985;147:49-57.
8. Wrba F, Fertl H, Amman G, et al. Epithelial markers in synovial sarcoma: an immunohistochemical study of paraffin-embedded tissues. Virchows Arch A Pathol Anat Histopathol. 1989;415:253-258.
9. Lopes JM, Bjerkehagen B, Holm R, et al. Immunohistochemical profile of synovial sarcoma with emphasis on the epithelial-type differentiation: a study of 49 primary tumours, recurrences and metastases. Pathol Res Pract. 1994;190:168-177.
10. Gray MH, Rosenberg AE, Dickersin GR, et al. Glial fibrillary acidic protein and keratin expression by benign and malignant nerve sheath tumors. Hum Pathol. 1989;20:1089-1096.
11. Meis JM, Enzinger FM, Martz KL, et al. Malignant peripheral nerve sheath tumors (malignant schwannomas) in children. Am J Surg Pathol. 1992;16:694-707.
12. Hirose T, Hasegawa T, Kudo E, et al. Malignant peripheral nerve sheath tumors: an immunohistochemical study in relation to ultrastructural features. Hum Pathol. 1992;23:865-870.
13. Hirose T, Scheithauer BW, Sano T. Perineurial malignant peripheral nerve sheath tumor (MPNST): a clinicopathologic, immunohistochemical, and ultrastructural study of seven cases. Am J Surg Pathol. 1998;22:1368-1378.
14. Moll R, Franke WW, Schiller DL, et al. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell. 1982;31:11-24.
15. Moll R, Lowe A, Laufer J, et al. Cytokeratin 20 in human carcinomas: a new histodiagnostic marker detected by monoclonal antibodies. Am J Pathol. 1992;140:427-447.
16. Wang NP, Zee S, Zarbo RJ, et al. Coordinate expression of cytokeratins 7 and 20 defines unique subsets of carcinomas. Appl Immunohistochem. 1995;3:99-107.
17. Swanson PE, Dehner LP, Sirgi KE, et al. Cytokeratin immunoreactivity in malignant tumors of bone and soft tissue: a reappraisal of cytokeratin as a reliable marker in diagnostic immunohistochemistry. Appl Immunohistochem. 1994;2:103-112.
18. Hazelbag HM, Mooi WJ, Fleuren GJ, et al. Chain-specific keratin profile of epithelioid soft-tissue sarcomas: an immunohistochemical study of synovial sarcoma and epithelioid sarcoma. Appl Immunohistochem. 1996;4:176-183.
19. Miettinen M. Keratin subsets in spindle cell sarcomas: keratins are widespread but synovial sarcoma contains a distinctive keratin polypeptide pattern and desmoplakins. Am J Pathol. 1991;138:505-513.
20. Machen SK, Fisher C, Gautam RS, et al. Utility of cytokeratin subsets for distinguishing poorly differentiated synovial sarcoma from peripheral primitive neuroectodermal tumour. Histopathology. 1998;33:501-507.
21. Wick M, Swanson P, Scheithauer B, et al. Malignant peripheral nerve sheath tumor: an immunohistochemical study of 62 cases. Am J Clin Pathol. 1987;87:425-433.
22. Fisher C, Schofield JB. S-100 protein positive synovial sarcoma. Histopathology. 1991;19:375-377.
23. Fetsch JF, Meis JM. Synovial sarcoma of the abdominal wall. Cancer. 1993;72:469-477.
24. Brown DC, Theaker JM, Banks PM, et al. Cytokeratin expression in smooth muscle tumors. Histopathology. 1987:11:477-486.
25. Norton AJ, Thomas JA, Isaacson PG. Cytokeratin-specific monoclonal antibodies are reactive with tumors of smooth muscle derivation: an immunohistochemical and biochemical study using antibodies to intermediate filament cytoskeletal proteins. Histopathology. 1987;11:487-499.
26. Rosenberg AE, O'Connell JX, Dickersin GR, et al. Expression of epithelial markers in malignant fibrous histiocytoma of the musculoskeletal system: an immunohistochemical and electron microscopic study. Hum Pathol. 1993;24:284-293.
27. Sreekantaiah C, Ladanyi M, Rodriguez E, et al. Chromosomal aberrations in soft tissue tumors: relevance to diagnosis, classification, and molecular mechanisms. Am J Pathol. 1994;144:1121-1134.
28. Turc-Carel C, Dal Cin P, Limon J, et al. Translocation X;18 in synovial sarcoma [letter]. Cancer Genet Cytogenet. 1986;23:93.
29. Shipley J, Fisher C, Kelsey A, et al. Interphase fluorescence in situ hybridization and reverse transcription polymerase chain reaction as a diagnostic aid for synovial sarcoma. Am J Pathol. 1996;148:559-567.
30. Kawai A, Woodruff J, Healey JH, et al. SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma. N Engl J Med. 1998;338:153-160.
31. Balazs L, Parham D, Shurtleff S, et al. Identification of the t(x;18) as a diagnostic tool in the differential diagnosis of synovial sarcomas versus peripheral nerve sheath tumors [abstract]. Mod Pathol. 1997;10:8.
32. Limon J, Dal Cin P, Sandberg AA. Translocations involving the X chromosome in solid tumors: presentation of two sarcomas with t(x;18)(q13;p11). Cancer Genet Cytogenet. 1986;23:87-91.
33. Mandahl N, Heim S, Arheden K, et al. Multiple karyotypic arrangements, including t(X;18)(p11;q11), in a fibrosarcoma. Cancer Genet Cytogenet. 1988;30:323-327.
34. van de Rijn M, Barr FG, Collins M, et al. Absence of the SYT-SSX fusion products in soft tissue tumors other than synovial sarcoma. Am J Clin Pathol. 1999;112:43-49.